SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-031501
Filing Date
2023-09-01
Accepted
2023-09-01 17:01:36
Documents
13
Period of Report
2023-08-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38571
  Complete submission text file 0001493152-23-031501.txt   206999

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vblt-20230829.xsd EX-101.SCH 3006
3 XBRL LABEL FILE vblt-20230829_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE vblt-20230829_pre.xml EX-101.PRE 22353
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3092
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36581 | Film No.: 231233285
SIC: 2834 Pharmaceutical Preparations